Control group:Routine treatment + placebo

2 trials

Sponsors

Chinese PLA General Hospital, Renmin Hospital of Wuhan University

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 2

Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)

Active, not recruitingChiCTR2000030138

Chinese PLA General HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-24Updated: 2020-02-25

Unknown Phase

Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients

Active, not recruitingChiCTR2000031319

Renmin Hospital of Wuhan UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-04-01Updated: 2020-03-30

Related Papers

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).

2020-06-1230 citations